MetaCap

Amylyx Pharmaceuticals Statistics

NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.02-0.18 (-0.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Amylyx Pharmaceuticals by the numbers

Amylyx Pharmaceuticals has a market capitalization of $3.35 billion based on 128.56M shares outstanding. With trailing EPS of $-1.43, Amylyx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.4% below its 50-day average and 23.2% above its 200-day average.

Average daily trading volume is 1.53M shares, or about $39.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AMLX valuation vs. peer median

AMLX compared with the median of 8 peer companies
MetricAMLXPeer medianDifference
Market cap$3.35B$3.37B-1%
Avg. volume1.53M2.36M-35%

Peer median across 8 companies: VRDN, ARQT, IRON, ELVN, PBLS, ABCL, VKTX, XERS.

Valuation

Price and trading

Previous close
26.20
Open
25.64
Day range
25.52 – 26.40
52-week range
10.83 – 41.14
52-week change
+77.37%
Beta
—
Volume
1.14M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.35B
Forward Pe
-22.07
Eps
-1.43
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
41.14
Week52 Low
10.83
Avg Volume
1.53M
Shares Outstanding
128.56M
Ma50
29.05
Ma200
21.12
Earnings Date
Nov 5, 2026
Pct From52w High
-36.75%
Pct From52w Low
140.26%

Related